Le Lézard
Classified in: Health, Business
Subjects: CON, LIC, SBS

2X NBA Champ Lamar Odom Joins Elevate as the New Face of Wellness


LOS ANGELES, Nov. 14, 2024 /PRNewswire/ -- Elevate is excited to welcome former NBA champion Lamar Odom as its new ambassador. Odom's journey is inspiring, and through this partnership, Elevate hopes to promote wellness and encourage healthier lifestyles. This collaboration is more than a standard endorsement; it represents a joint goal of making wellness accessible to everyone. Odom's life experiences align with Elevate's focus on quality products that support well-being, offering hope and motivation for those aiming to improve their health and find balance. "Partnering with Odom aligns perfectly with Elevate's mission to prioritize well-being," said Emil, CEO of Elevate. "His approach to a healthier lifestyle resonates with our values, and we're thrilled to work together to challenge outdated perceptions and advocate for a more natural path to better living."

The partnership will feature Odom in various campaigns across digital, social, and traditional media, where he will share insights and highlight Elevate's wellness products. The brand offers a variety of 2018 Farm Bill-compliant THC and CBD-infused items, including tinctures, gummies, vapes, and capsules, all crafted to promote physical and mental health. With a focus on quality ingredients, the products meet high standards, ensuring that customers receive safe and effective options for their wellness needs. Odom was selected for this role because he genuinely connects with people who are going through tough times. His experiences give him a strong, credible voice in the wellness field, making him a perfect fit for Elevate. His commitment to mental health and whole-body wellness aligns well with the brand's values, helping promote more balanced lifestyles. This collaboration represents a significant move toward connecting with individuals seeking effective and natural health solutions.

Elevate is confident that Odom's story and genuine advocacy will resonate with a wide audience, empowering others to make informed choices about their health. This collaboration not only reinforces the brand's commitment to quality but also introduces a fresh and relatable perspective on wellness.

For more details about the partnership and upcoming campaigns, visit https://elevateright.com/ 

About Elevate
Elevate offers premium THC and CBD-infused products crafted to support well-being. The brand is dedicated to using natural ingredients, ensuring quality in its range of wellness solutions designed to promote balance in daily life.

Contact
Eli Ackermann
(877) 355-0033
Email: [email protected] 

SOURCE Elevate


These press releases may also interest you

at 12:55
Vertex Pharmaceuticals Incorporated today announced longer-term data for CASGEVYtm (exagamglogene autotemcel) from global clinical trials in people with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). CASGEVY is the...

at 12:35
Kite, a Gilead Company , today announced findings from three new analyses for Yescarta® (axicabtagene ciloleucel) that demonstrate improved outcomes for people living with relapsed or refractory (R/R) large B-cell lymphoma (LBCL), which were...

at 12:35
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today data from a five-year follow-up of the pivotal Phase III POLARIX study evaluating Polivy® (polatuzumab vedotin-piiq) in combination with Rituxan® (rituximab),...

at 12:35
bluebird bio, Inc. today announced new and updated data from LYFGENIAtm (lovotobegligene autotemcel, or lovo-cel) gene therapy for patients with sickle cell disease who have a history of vaso-occlusive events (VOEs). The data will be presented at...

at 12:33
Johnson & Johnson today announced new frontline data featuring TECVAYLI® (teclistamab-cqyv) from two investigational studies in patients with newly diagnosed multiple myeloma (NDMM) in induction and maintenance settings. The MajesTEC-5 (Abstract...

at 12:30
- Study clarifies impact of CAR T-cell therapy in transformed follicular...



News published on and distributed by: